Send Message
801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsSmall Volume Parenteral

Diclofenac Sodium Injection Small Volume Parenteral 75mg/3ml analgesic anti-inflammatory

Diclofenac Sodium Injection Small Volume Parenteral 75mg/3ml analgesic anti-inflammatory

  • Diclofenac Sodium Injection Small Volume Parenteral 75mg/3ml analgesic anti-inflammatory
Diclofenac Sodium Injection Small Volume Parenteral 75mg/3ml analgesic anti-inflammatory
Product Details:
Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 75mg/3ml
Payment & Shipping Terms:
Minimum Order Quantity: 300, 000 amps
Price: Negotiation
Packaging Details: 10 x 10amps/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: one million amps per day
Contact Now
Detailed Product Description
Product: Diclofenac Sodium Injection Specification: 75mg/3ml
Standard: BP, USP Packing: 10 X 10amps/box
High Light:

lyophilized injection


anti cancer drugs

Diclofenac Sodium Injection Small Volume Parenteral 75mg/3ml analgesic anti-inflammatory



Product : Diclofenac Sodium Injection

Specification : 75mg/3ml

Standard : BP, USP

Packing : 10 x 10amps/box



Description :

Diclofenac sodium belongs to a class of medicines called non-steroidal anti-inflammatory drugs ( NSAIDs). Diclofenac sodium helps to reduce inflammation and to reduce pain. Diclofenac sodium works by blocking the production of some of the body chemicals that cause inflammation, pain, stiffness, tenderness, swelling and increased temperature.

By reducing inflammation in conditions affecting muscles and joints Diclofenac sodium helps to increase strength and movement.


Indication and Usage :

Diclofenac is a non-steroidal anti-inflammatory drug (NSAID). NSAIDs are prescribed for adults and the elderly for treatment of painful conditions, such as kidney stone pain,osteoarthritis (degeneration of joints) and rheumatoid arthritis (inflammation of joints), backpain, gout (formation of crystals in joints), injuries and fractures.


Pharmacodynamics :

Diclofenac is an acetic acid nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Diclofenac is used to treat pain, dysmenorrhea, ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and actinic keratosis


Mechanism of action :

The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.


Contraindications :

Active GI bleeding or ulcers; asthma attacks, rhinitis, or urticaria from aspirin or other NSAIDs; hypersensitivity to diclofenac or NSAIDs; treatment of perioperative pain after coronary artery bypass grafting


Interactions :

Drugs :

acetaminophen: Increased risk of adverse renal effects with long-term concurrent use anticoagulants, thrombolytics: Prolonged PT, increased risk of bleeding

antihypertensives: Decreased anti-hypertensive effectiveness aspirin, other NSAIDs, salicylates: Increased GI irritability and bleeding, decreased diclofenac effectiveness

beta blockers: Impaired antihypertensive effect

cefamandole, cefoperazone, cefotetan, plicamycin, valproic acid: Increased risk of hypoprothrombinemia

cimetidine: Altered blood diclofenac level colchicine, corticotropin (long-term use), glucocorticoids, potassium supplements: Increased GI irritability and bleeding cyclosporine, gold compounds, nephrotoxic drugs: Increased risk of nephrotoxicity CYP2C9 inducers such as rifampin: Decreased effectiveness of diclofenac CYP2C9 inhibitors such as voriconazole: Increased risk of diclofenac adverse reactions and toxicity digoxin: Increased blood digoxin level insulin, oral antidiabetics: Decreased effects of these drugs

lithium: Increased risk of lithium toxicity loop diuretics: Decreased diuretic effects

methotrexate: Increased risk of methotrexate toxicity

phenytoin: Increased blood phenytoin level potassium-sparing diuretics: Increased risk

of hyperkalemia

probenecid: Increased diclofenac toxicity


food: Delayed absorption of delayed-release tablets


alcohol use: Increased risk of GI irritability and bleeding

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Mr. Luke Liu

Tel: 86--57487019333

Fax: 86-574-8701-9298

Send your inquiry directly to us (0 / 3000)

Other Products